共 50 条
Cancer immunotherapy in routine cost-effective cancer care?
被引:2
作者:
Feldmann, Sir Marc
[1
]
机构:
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
关键词:
ANTIBODY;
D O I:
10.15252/emmm.201809660
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Therapy-triggered autoimmunity and inflammation in many cancer patients, as well as treatment costs, hamper the success of cancer immunotherapy. The study by Pfeiffer et al in this issue of EMBO Molecular Medicine constitutes a clear step towards a more simple, scalable and affordable approach in generating in situ T cells reprogrammed with chimeric antigen receptors (CARs) (Pfeiffer et al, ).
引用
收藏
页数:2
相关论文